Skip to content

BD² powers collaborative science to transform how bipolar disorder is understood and treated, supporting multidisciplinary teams that push discovery toward real‑world impact.

Science funding icon

Since launch, BD² has invested $105M+ in research commitments.

Funding Opportunities:
Requests for Applications (RFAs)

Showing 1 of 1 results.
Title Description Amount Year/Status RFA Links
Genetics Platform

Genetics Platform

The Genetics Platform advances our understanding of bipolar disorder genetics, including nuclear and mitochondrial genetics. Our partners collect and genotype an unprecedented quantity and diversity of samples from people with bipolar disorder to decode the complex genetic architecture of the disorder.

Amount: up to $10,000,000
over 2 years
Year/Status: 2022Inactive Download RFA